Vimpat and Dementia - a phase IV clinical study of FDA data

Summary:

Dementia is reported as a side effect among people who take Vimpat (lacosamide), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Keppra, and have Depression.

The phase IV clinical study analyzes which people have Dementia when taking Vimpat. It is created by eHealthMe based on reports of 20,279 people who have side effects when taking Vimpat from the FDA, and is updated regularly.

What is Vimpat?

Vimpat has active ingredients of lacosamide. It is often used in epilepsy. eHealthMe is studying from 20,831 Vimpat users. Check the latest studies of Vimpat.

What is Dementia?

Dementia (madness) is found to be associated with 1,206 drugs and 1,808 conditions by eHealthMe. Check the latest studies of Dementia.

On Jul, 16, 2026

20,279 people reported to have side effects when taking Vimpat.
Among them, 43 people (0.21%) have Dementia.

Among these 43 people:

How long have people been on Vimpat when they have Dementia? *

What is the gender of people who have Dementia when taking Vimpat? *

female: 50 %
male: 50 %

What is the age of people who have Dementia when taking Vimpat? *

What are other drugs people take besides Vimpat? *

What are other side effects people have besides Dementia? *

Fatigue (feeling of tiredness): 14 people, 32.56%
Fall: 11 people, 25.58%
Balance Disorder: 11 people, 25.58%
Swallowing Difficulty: 11 people, 25.58%
Memory Loss: 10 people, 23.26%
Nausea (feeling of having an urge to vomit): 10 people, 23.26%
Mental Status Changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation): 9 people, 20.93%
Weakness: 9 people, 20.93%
Nausea And Vomiting: 7 people, 16.28%
Confusional State: 6 people, 13.95%

What are the existing conditions these people have? *

Stress And Anxiety: 7 people, 16.28%
Depression: 7 people, 16.28%
Constipation: 6 people, 13.95%
Partial Seizures (seizures which affect only a part of the brain at onset): 6 people, 13.95%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 5 people, 11.63%
Agitation (state of anxiety or nervous excitement): 4 people, 9.30%
Dehydration (dryness resulting from the removal of water): 4 people, 9.30%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 4 people, 9.30%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 9.30%
Tardive Dyskinesia (a disorder that involves involuntary movements): 3 people, 6.98%

* Approximation only. Some reports may have incomplete information.

Do you take Vimpat and have Dementia?

- Check whether Dementia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vimpat:

Vimpat (20,831 reports)

Dementia treatments and more:

Dementia (44,271 reports)

Browse all side effects of Vimpat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dementia:

Dementia (1,206 drugs)

Browse all the conditions that are associated with Dementia:

Dementia (1,808 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lacosamide (the active ingredients of Vimpat) and Vimpat (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.